Abciximab and Heparin Versus Bivalirudin for Non–ST-Elevation Myocardial Infarction

Study Questions:

What is the effect of abciximab with unfractionated heparin, as compared with bivalirudin, on clinical outcomes in patients with acute non–ST-segment elevation myocardial infarction (NSTEMI) who are undergoing percutaneous coronary intervention (PCI)?